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Recent evidence revealed that reactive oxygen species (ROS) such as
superoxide (O ) and hydrogen peroxide (H O ), which are conventionally2.- 2 2
viewed as unwanted and toxic by-products of life in an aerobic environment,
have physiological roles. Appraisal of the roles of reactive NO species
(RNOS), such as nitrosonium (NO ) and nitroxyl (NO ) ions, peroxynitrite+ -
(OONO ), and higher nitrogen oxides (NO ) in NO mediated processes, is- x
growing at a rapid rate. ROS and RNOS may evoke a variety of cellular
responses, ranging from major changes in mammalian cell gene expression
to apoptotic death. The greater prevalence and reactivity of thiols over other
biological nucleophiles makes them targets for both ROS and RNOS. Any
essential protein containing cysteine residue that is strategically located at
either active or allosteric site should be considered as a target for regulation
by ROS and/or RNOS. Candidate molecules include proteins that are
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themselves involved in signal transduction processes, ion channels, receptors,
G-proteins, protein-kinases, protein phosphatases, and transcription-activating
factors. In this paper the mechanisms of generation of ROS and RNOS and
their reactions with thiols are briefly described. The regulation of cell
processes by ROS and RNOS is illustrated by the interference of ROS and
RNOS effects with receptor tyrosine kinases signaling. 
Key words: NO-dismutation, reactive oxygen species (ROS), reactive
NO species (RNOS), redox signaling, thiols
INTRODUCTION
Nitric oxide (NO) has gained wide attention for its role as an ubiquitous intra- and
intercellular messenger and cytotoxin. A variety of physiological as well as
pathophysiological roles of NO have been elucidated in recent years (Moncada et al.,
1991; Bredt and Snyder, 1994). The heme group of soluble guanilate cyclase is one of
the most sensitive and important sites of action of NO, based on the well established
role of cGMP in many NO-mediated responses (Bredt and Snyder, 1994). Indeed,
evidence for a physiological role of NO was preceded by studies demonstrating cGMP
formation in response to nitroglycerin and other NO-donors (Milovanoviü et al., 1984,
1985; Bredt and Snyder, 1994). The reversible reactions of NO with a number of other
heme proteins have been studied extensively. It was found that NO activates
cyclooxygenase (Gross and Wolin, 1995) and inhibits a host of other heme proteins
such as cytochrome oxidase, lipoxygenases, peroxidases (Stamler, 1994; Radi, 1996)
and catalase (Brown, 1995; Dusinoviü et al., 1998). In addition to its reactions with
heme proteins, it is well established that in the biological milieu NO takes part in
diverse reactions yielding highly reactive species such as nitrosonium (NO ) and+
nitroxyl (NO ) ions, peroxynitrite, and higher nitrogen oxides (NO ) that are more- x
reactive than NO itself. Appraisal of the roles of these reactive NO species (RNOS) in
NO mediated processes is growing at a rapid rate (Stamler et al., 1992; Stamler, 1994;
Gross and Wolin, 1995; Wink et al., 1996).
Recent evidence demonstrate that reactive oxygen species (ROS) such as
superoxide (O ) and hydrogen peroxide (H O ), which are conventionally regarded as2 2 2
.-
unwanted and toxic by-products of life in an aerobic environment, may play
physiological roles in diverse cell events. Observation that stimuli to specific
cell-surface receptors are associated with a production of ROS puts the action of ROS
into an even more persuasive physiological context (Suzuki et al., 1997; Nakamura et
al., 1997; Finkel, 1998; Kourie, 1998).
Both ROS and RNOS function in two discrete fashions: high amounts are
cytotoxic, and when produced by macrophages and other immune-effector cells, they
play a role in host defense. However, when produced at low, subtoxic level they serve
physiological functions. Effects of RNOS resemble those of ROS in evoking a variety
of cellular responses ranging from major changes in mammalian cell gene expression
to apoptotic death (Herlich and Rahmsdorf, 1994; Polyak et al., 1997; Kroemer et al.,
1998, Brune et al., 1998; Marquis and Demple, 1998).
The greater prevalence and reactivity of thiols over other biological nucleophiles
makes them targets for both ROS and RNOS. Any essential protein containing cysteine
residue that is strategically located at either active or allosteric site should be considered
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Other oxygen free radicals and oxidants that can be formed in living systems include lipid*
(L ) and other (X) peroxy radicals (LOO  and XOO ) lipid peroxide (LOOH), singlet. . .
oxygen ( O ), hypochlorous acid (HOCl) and other N-chloramine compounds.1 2
a target for regulation by ROS and/or RNOS. Candidate molecules include proteins that
are themselves involved in signal transduction processes, ion channels, receptors,
G-proteins, protein-kinases, protein phosphatases, and transcription-activating factors.
A number of protein-kinases were shown to be activated by ROS or RNOS induced
modifications of their cysteine residues (Gopalakrishna and Gundimeda, 1993; Konishi
et al., 1997; Gotoh and Cooper, 1998). On the other hand, activation of certain tyrosine
kinases seems to be due to the inhibition of specific tyrosine phosphatases caused by
ROS or RNOS modifications of cysteine residue in their active centres (Knebel et al.,
1996; Duarte, 1997). Nitrosylation/ thiolation of critical Cys-residue in p21  wasras
shown to activate this small G-protein, which was suggested to represent the central
mechanism by which a variety of redox stress stimuli transmit their signal to nuclei
(Lander et al., 1995). The ROS/RNOS induces redox-sensitive transcription factors
AP-1 and NF- B (Schreck et al.,1991; Peunova and Enikolopov, 1993; Lander et
al.,1993).
In this paper, mechanisms of generation of ROS and RNOS and their reactions
with thiols will be briefly discussed. Since our primary aim is to interpret rather than
exhaustively summarize the large body of accumulated literature, only the examples of
ROS and RNOS interference with receptor tyrosine kinases (RTK) signaling will be
described in more detail. Specific ligand stimuli to RTKs were shown to be associated
with ROS generation. ROS and RNOS activate RTKs and affect also downstream
components of RTKs cell signaling complex.
SOURCES OF ROS
Reactive oxygen species (ROS) include oxygen free radicals and molecules that
are more strongly oxidizing than molecular oxygen itself. These are superoxide anion
radical (O ), hydrogen peroxide (H O ), and hydroxyl radical (HO ) . There is a large2.- . *2 2
number of intracellular and extracellular sources of ROS. O  and H O  are produced2 2 2
.-
in large amounts by cells of the immune systems, whereas other cell types, appear to
produce significantly lower amounts of these molecules (Simoviü et al., 1995). The vast
network of intracellular and extracellular anti-oxidant defenses point out that the level
of ROS must be tightly regulated for the cell survival. Antioxidant defense in mammals
is a rather complex system, being species-, organ-, and tissue-specific (Buzadåiü et al.,
1990a; 1990b; Spasiü et al., 1993; Simoviü et al., 1995), and its regulation is closely
connected to the regulation of the principal metabolic functions (Petroviü et al, 1980;
1982; 1983; 1991). The principal sources of ROS and mechanisms of antioxidant
defense are summarized in Fig. 1.
SOURCES OF RNOS
Mammalian cells possess at least three genes encoding distinct isoforms of NO
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Fig 1. Reactive oxygen species and antioxidant defense: Vitamin C (AsA) acts
as a cytosolic antioxidant; vitamin E acts as membrane antioxidant, reduced
glutathione (GSH) protect both cytosol and membranes against ROS. Also
present are the glutathione-containing enzymes glutathione peroxidase
(Se-GSH-Px), glutathione reductase (GR), catalase (CAT) and superoxide
dismutase (SOD). Some of these enzymes exist in several forms. Membrane,
cytosolyc and plasma forms of GSH-Px have all been reported. Similarly, there
are mitochondrial, cytosolic, and extracellular forms of SOD (modified from
Spasiü, 1993).
synthase (NOS). Two NOS gene products are constitutively expressed: one (eNOS) in
endothelial cells, and second (nNOS) in the neuronal and number of other cell types.
The third species of NOS is inducible by immunological stimuli in virtually all
nucleated mammalian cells examined (iNOS). Both eNOS and nNOS produce a small,
physiological increase of NO concentration in response to transient elevation of
intracellular calcium, whereas iNOS produces a large and continuous flux of NO until
substrate becomes limiting. NOS is one of the most regulated enzymes in biology. All
three NOS isoforms oxidize the guanidine group of L-arginine in a process that
consumes five electrons and results in the formation of NO with stochiometric
formation of L-citruline (Bredt and Snyder, 1994; Gross and Wolin, 1995). 
Nitric oxide is a relatively stable gas, that after a currently accepted paradigm,
readily diffuses into cells and cell membranes (Lancaster, 1997; Chen et al., 1998)
where it reacts with molecular targets: transition metal centers, superoxide anion, and
molecular oxygen (Fig. 2). 
The reactions of NO with transition metal centers constitute the basis of NO
actions in biological systems (Moncada et al., 1991). In the majority of metal-nitrosyl
complexes, bonding of the NO group to the central metal atom may be regarded as
covalent, formed between NO  and a metal ion that has been reduced by one oxidation+
state unit. NO  complexes may be formally regarded as resulting from bonding between-
NO  and the metal atom that has been oxidized by one unit. Indeed, metal-catalysed-
reduction of NO has been postulated as a possible source of NO  (Bonner and Pearsall,-
1982). In a limited number of instances nytrosyl complexes are best described as
Vesna NIKETIû et al: CELL REGULATION BY ROS AND RNOS 467
Fig. 2. Summary of NO reactions in biological systems that 
reactions with cell thiols to form RS-NO, disulphides, and a number of
intermediates such as RSNHOH (for details see text). 
containing a neutral NO molecule (Bonner and Stedman, 1996).
Our recent in vitro study demonstrated that NO-treatment of Mn and Fe SOD, but
not Cu/Zn SOD gives rise to reactive nitrosyl complexes that generate both NO  and+
NO- ions. NO reacts with Mn and FeSODs presumably according to the following
reaction schemes (Niketiü et al., 1999): 
E    +   NO      E    +   NOred ox
-
E    +   NO      E    +   NOox red
+
The generation of NO  and NO by Mn and FeSODs is analogous to the well+ - 
known dismutation reaction of O  by SODs to generate O  and H O  (Michelson,2 2 2 2
.-
1987). Therefore, we suggest the term NO-dismutation for the above described
reactions. It seems that Mn and FeSOD induced NO-dismutation reaction may not be
an exception in the biological milieu. Indeed, our recent in vitro studies demonstrated
that in CSFs of both ALS patients and normal individuals, ill-defined low molecular
Fe complexes exist which are able to dismutate NO efficiently (Niketiü et al., 1999).
Peroxynitrite (ONOO ) is formed in the near-diffusion controlled reaction between-
NO and O . Thus the formation of ONOO  will predominate in any setting where NO2
.- -
and O  are simultaneously produced, e.g., in an inflammatory lesion (Wink et al.,2
.-
1996). 
The products formed from NO/O  reaction in gas phase and hydrophobic media2
i.e. NO , N O  and N O  are well characterized. However, the true nature of higher2 2 3 2 4
nitrogen oxides (NO ) formed upon oxidation of NO with O  in aqueous media remainsx 2
disputable. The reaction between NO and O  was shown to occur via third- order2
kinetics, with nearly identical rates in any biological medium. Therefore, under
physiological conditions the interference from NO/O  reaction is considered minimal.2
However, under the conditions of higher NO concentrations the rate of its oxidation
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exponentially increases (Wink et al., 1996).
REACTIONS OF ROS AND RNOS WITH THIOLS
Sulphydryl groups in proteins, free cysteine, and GSH represent abundant sources
of reduced thiols in biological systems. The concentration of protein SH (PSH) groups
in the cell is far greater than that of the metabolically most important thiol GSH
(Simplicio et al., 1998). There is an increasing body of evidence on proteins having
reactivities similar to or higher than that of GSH. The intrinsic reactivity of PSH with
ROS and RNOS will depend not only on their pKa but also on other structural features,
such as their accessibility; moreover in allosteric proteins the -SH reactivity may be
expected to be influenced by ligands.
A feasible mechanism for O  and H O  induced disulphide formation involve an2 2 2
.-
oxyradical initiated mechanism. By this mechanism protein sulphydryl groups are
activated by reaction with O /H O , and then the activated proteins react with GSH or2 2 2
.-
with other protein SH groups. The process is rapid, it does not require extensive
oxidation of cellular glutathione, and it might occur at localized sites in close proximity
to the site of O /H O  generation. Further support for this mechanism is found in2 2 2
.-
recently observed hemoglobin thiyl radical in erythrocytes exposed to O /H O2 2 2
.-
(Maples et al., 1990) followed by detection of glutathione adduct of hemoglobin in vivo
(Niketiü et al.,1992). 
The free sulphydryl groups will be restored by the thiol-disulphide exchange
catalyzed by thiol-transferases in the presence of excess of GSH. Because the
thiol-transferase reaction is bidirectional, the equilibrium will be determined by the
redox state of the cell, i.e. in the excess of GSH it will be shifted to the right (Wang
and Ballatori, 1998):
Thiol transferases
    RS-SR' + GSH         RS-SG + R'SH
    RS-SG + GSH          RSH + GSSG
Under anaerobic conditions, NO reacts directly with low molecular weight thiols
at physiological pH yielding stable end products: disulphide and nitrous oxide (Pryor
et al., 1982). Thiol proteins under the same conditions can yield sulfenic acid
(DeMaster et al., 1995). It has been suggested recently that NO may react directly with
thiols to form S-nitrosothiol in the presence of an electron acceptor (Gow et al., 1997).
Peroxynitrite is more reactive with sulphydryls than H O . Low molecular weight2 2
thiols are oxidised with peroxynitrite to predominantly disulphide forms (Fig. 2), while
steric restrictions due to the size of the molecule or the location of SH groups may
preclude disulphide formation in protein molecules. Peroxynitrite may oxidize protein
SH groups beyond the disulphide (Radi et al., 1991). 
Under physiological conditions NO  is rapidly converted to N O and reacts with- 2
O  to yield peroxynitrite (Stamler et al., 1992). The competing two step reaction with2
thiol groups results in the formation of disulphide and hydroxylamine (Fig. 2) (Wink
et al., 1996). 
S-nitrosothiols (RSNO) are efficiently formed upon reaction of thiols with
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nitrosating agents (NO  donors) and NO  (Fig. 2) (Stamler et al., 1992; Stamler 1994.;+ x
Wink et al., 1996). They show varying degrees of stability under physio-logical
conditions. For example, S-nitrosoglutathione (GSNO) undergoes decompo-sition over
hours, whereas S-nitrosocysteine has a half life of less than 2 min (Singh et al., 1996).
Their decomposition to yield disulphides is strongly catalyzed by transition metal ions
(McAninly et al., 1993). For any system containing thiol (R'SH) and S-nitrosothiol
(RSNO) the rapid transnitrosation (exchange reaction) is characteristic, but the reaction
seems to be more complex than might be inferred from the few final reaction products
(Singh et al., 1996).Glutathione readily reacts with S-nitrosothiols, forming the stable
GSNO in cells . It was demonstrated recently that in restoration of free GSH reducing
agents such as ascorbic acid (Iwatsuki, 1997) and the thioredoxin system (Nikitoviü and
Holmgren, 1996) may be involved.
The biological activity of S-nitrosothiols is thought to be associated with both
heterolytic and homolytic mechanisms of decomposition (Garley and Stedman, 1988).
RSNOs retain NO-like bioactivity, but exhibit resistance to reactions with O  and O .2 2
.-
For that reason, the S-nitrosated proteins, the most abundant of which is serum
albumin, are thought to serve as a source and sink of NO, buffering the concentration
of free NO (Stamler et al., 1992).
The detection of S-nitrosated proteins in vivo and evidence that such chemical
modification can alter protein activity have led to the view that nitrosation of protein
thiols may be a fundamental to signal transduction process (Stamler et al., 1992;
Stamler, 1994). S-nitrosation of a protein can regulate its activity by several discrete
mechanisms. It may bring about a conformational change by altering intramolecular
hydrogen bonding or electrostatic interactions. If located in the immediate vicinity of
an intramolecular thiol it may accelerate disulphide formation (Stamler, 1994). 
INTERFERENCE OF ROS AND RNOS WITH 
RECEPTOR TYROSINE KINASES (RTKs) SIGNALING 
Numerous studies have demonstrated that ligand stimulation of non-phagocytic
cells results in an increase in intracellular ROS. This has been observed in a wide
variety of cell types and is stimulated by a diverse collection of ligands, including
growth factors acting through tyrosine kinases (Finkel, 1998). ROS were shown to
activate RTKs and regulate downstream tyrosine phosphorylation (Sundaresan et al.,
1995; Bae et al., 1997). The primary source of ligand activated ROS-generating system
seems to be NADPH oxidase functionally similar to the neutrophil NADPH oxidase
(Finkel, 1998). The intracellular pathway in non-phagocytic cells leading from ligand
activation to ROS generation appears to require also small GTP-binding proteins Ras
and Rac1. This further supports the hypothesis that ROS may serve as intracellular
second messengers and suggest that small GTP-binding proteins regulate
redox-sensitive signal-transduction pathways (Sundersan et al., 1996). These findings
suggest that ligand stimulation of cells may activate two separate but interrelated
pathways. One well cha-racterized pathway leads to the modification of protein by
phospho-rylation of critical tyrosine residues. The other pathway, also con-trolled by
small GTP-binding proteins, presumably would result in the generation of transient,
highly local-ized, burst of ROS which will lead to the modification of protein functions
by the oxidation of critical cysteine residues.
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Figure 3. Interference of ROS and RNOS with RTKs signaling. (+) indicates
activation and (-) inhibition. Black patches on the cytoplasmic domain of the receptor
indicate the tyrosine phosphates to which signaling proteins bind. Increase in ROS
causes oxidation of cysteine residue at the active center and consequent transient
inhibition of tyrosine phosphatases (TPA), which temporarily permits a burst of kinase
activity. Phosphorylation of RTKa triggers the assembly of an intracellular signaling
complex on the receptor tail. The newly phosphorylated tyrosines serve as binding
sites for different intracellular signaling molecules. The complex then broadcasts
signals along multiple routes to many destinations inside the cell, activating and
coordinating the numerous biochemical changes needed to trigger a complex response
such as a cell proliferation. Each activating receptor produces multiple outputs (for
details see: Bray, 1998).
ROS were shown to stimulate activities of various receptor and non-receptor
tyrosine kinases (Suzuki et al.,1997; Finkel, 1998). Indeed, patterns of H O  induced2 2
epidermal growth factor (EGF) and insulin RTKs phosphorylation were found to be
identical with those induced by the natural ligands (Gamou and Shimizu, 1995).
Responses by RNOS closely resemble those of ROS (Lander et al. 1993; Stamler,
1994; Martin et al., 1998). However, whereas ligand stimulation results in transient,
highly localized burst of ROS which activates only specific RTKs, RNOS and ROS
produced by other sources may induce a multitude of RTKs which lead to the
activation of a numerous downstream signaling pathways. It is likely that the
stimulation by specific growth factor may activate strong signaling to the nucleus while
part of the signaling induced by ROS or RNOS may be neutralized and not reach the
nucleus (Knebel et al., 1996) (Fig. 3).
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How do oxidants activate tyrosine kinases? It is not yet clear whether reactive
species cause direct activation of tyrosine kinases or the observed increase in tyrosine
phosphorylation is due to inhibition of tyrosine phosphatases. Because all
protein-tyrosine phosphatases have reactive cysteine residues in their active centers
(Fischer et al., 1991), the inhibition of tyrosine phosphatases may account for the
mechanisms of stimulation of tyrosine phosphorylation by ROS and RNOS (Fig. 3).
Receptor tyrosine kinase activation requires homo- or heterodimerization
(Spivak-Kroizman et al., 1994). It was documented that a considerable fraction of
EGFR and platelet derived growth factor receptors (PDGFR) are in close association
in the absence of ligand and exhibit intrinsic tyrosine kinase activity. However, under
basal conditions tyrosine phosphatase activity predominates, since the specific activity
of tyrosine phosphatases is several orders of magnitude greater than that of the
corresponding tyrosine kinases. Increase in ROS causes oxidation of cysteine residue
at the active center and consequent transient inhibition of tyrosine phosphatases, which
temporarily permits a burst of kinases activity. It seems that RTKs as well as
cytoplasmic tyrosine kinases are under the control of different phosphatases, which can
be differently affected with ROS, and thus the signal transduction may vary (Knebel
et al., 1996).
The effects of ROS/RNOS and antioxidants on steps further downstream are less
predictable. It was shown that H O  induces tyrosine phosphorylation of the Src family2 2
protein tyrosine kinases (Nakamura et al., 1993), nitrosation/thiolation of critical
Cys-residue activates p21  (Lander et al., 1995) and the ROS/RNOS may activateras
redox-sensitive transcription factors AP-1 and NF-B (Devary et al., 1993; Lander,
1993; Stamler, 1994) 
CONCLUDING REMARKS
ROS and NO fulfill several criteria as possible signaling molecules. They are small
diffusible species that are ubiquitously present and can be rapidly synthesized and
destroyed. Contrary to conventional biosignaling ligands that act by binding to specific
receptor molecules, the biological actions of NO and ROS are dictated by the reactions
they undergo with target molecules in cells, membranes, and the extracellular milieu.
The ROS and NO initiated processes are rapid enough to be of metabolic significance.
They are very site directed since the reactivity of radicals suggests that they do not
diffuse far before participating in chemical reactions. 
Oxidation/reduction and nitrosation of critical SH-groups in proteins caused by
ROS and/or RNOS may be more widely exploited as a regulatory principle than is
currently assumed. In other words, continuum of ROS and RNOS (reversible)
modifications of cysteine residues may constitute biological signaling events. The
alteration of protein function by ROS and RNOS may be in many ways analogous to
phosphorylation except that protein modification no longer occurs on specific serine
or tyrosine residues but instead on redox sensitive cysteine residues.
The protein kinases and protein phosphatases seem to be well suited for the
regulation via oxidation/reduction and/or S-nitrosation. But, significant work needs to
be done in identifying direct targets of ROS and RNOS, the molecular basis of ROS
and RNOS sensitivity in proteins, and the relevant sources of their production. Such
work will hopefully provide some understanding of how specificity can be achieved
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using ROS and RNOS as signal transducers. The relative importance of other post-
translational modifications of proteins, which arise from direct reaction with ROS and
RNOS species such as tyrosine nitration, which are expected to occur under toxic
conditions, are yet to be realized.
ROS and RNOS have been postulated to be contributors to the pathogenesis of a
number of diseases, including arteriosclerosis, cancer, and Alzheimer's disease.
Interestingly, clinical and epidemiologic studies have, in some cases, indicated that
antioxidant nutrients may be effective in disease prevention (Palmer and Paulson,
1997). Discoveries that ROS/RNOS and antioxidants can directly affect the cellular
signaling apparatus and, consequently, the control of gene expression may provide the
link between ROS/RNOS and antioxidant chemistries and the mechanisms of disease
processes and prevention.
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